VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization

NCT06873321 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Arterial Disease
Venous Thormboembolism
Cardiovascular Diseases
Vascular Surgery Patient with PAD / Carotid Stenosis

Interventions

DRUG: rivaroxaban 2.5 mg bid + aspirin 100 mg
DRUG: clopidogrel 75 mg od for 3 months followed by aspirin 100 mg od for endovascular procedures or aspirin for open procedures

Sponsor

Science Valley Research Institute